{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:50:06Z","timestamp":1761177006017,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.tracli.2023.08.001","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T11:48:28Z","timestamp":1691408908000},"page":"421-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of thrombocytapheresis on hemogram and biochemistry parameters in patients with essential thrombocytemia"],"prefix":"10.1016","volume":"30","author":[{"given":"Ahmet","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130rfan","family":"Kuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ali","family":"Erkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lhami","family":"Berber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soykan","family":"Bi\u00e7im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Hidayet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"C\u0131r\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00fcleyman","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma Hilal","family":"Yagin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Sar\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2023.08.001_b0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/asheducation-2009.1.621","article-title":"Pathogenesis and management of essential thrombocythemia","author":"Beer","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.tracli.2023.08.001_b0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2023.08.001_b0015","first-page":"537","article-title":"Essential thrombocythemia: a retrospective study of the clinical course of 100 patients","volume":"75","author":"Chistolini","year":"1990","journal-title":"Hematological"},{"key":"10.1016\/j.tracli.2023.08.001_b0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","article-title":"Clinical course of essential thrombocythemia in 147 cases","volume":"66","author":"Fenaux","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.tracli.2023.08.001_b0025","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policeemia","volume":"123","author":"Policitemia","year":"1995","journal-title":"Anne Intern Med."},{"key":"10.1016\/j.tracli.2023.08.001_b0030","first-page":"2440","article-title":"Essential thrombocythemias","volume":"58","author":"Bellucci","year":"1986","journal-title":"Clin Evolutionary Biol Data Cancer"},{"key":"10.1016\/j.tracli.2023.08.001_b0035","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand disease in myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2023.08.001_b0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1986.tb07497.x","article-title":"Von Willebrand factor abnormalities in myeloproliferative disease: an association with bleeding diathesis","volume":"63","author":"Fabris","year":"1986","journal-title":"BrJ Haematol"},{"key":"10.1016\/j.tracli.2023.08.001_b0045","first-page":"647","article-title":"Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis","volume":"91","author":"Raman","year":"1989","journal-title":"I'm JClin Pathol"},{"key":"10.1016\/j.tracli.2023.08.001_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<168::AID-AJH6>3.0.CO;2-W","article-title":"Thrombotic complications in essential thrombocythemia with relatively low platelet counts","volume":"56","author":"Regev","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2023.08.001_b0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1526-0968.2002.00394.x","article-title":"The role of blood component removal in essential and reactive thrombocytosis","volume":"6","author":"Greist","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.tracli.2023.08.001_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","article-title":"Bleeding and thrombosis in the myeloproliferative disorders","volume":"64","author":"Schafer","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2023.08.001_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1986.tb07497.x","article-title":"Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis","volume":"63","author":"Fabris","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2023.08.001_b0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.00367.x","article-title":"A single institutional experience with 43 pregnancies in essential thrombocythemia","volume":"66","author":"Wright","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tracli.2023.08.001_b0075","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/1053-0770(94)90168-6","article-title":"Essential thrombocythemia and coronary artery bypass surgery","volume":"8","author":"Sch\u00f6tt","year":"1994","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.tracli.2023.08.001_b0080","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.2015.8515","volume":"314","author":"Al","year":"2015","journal-title":"Trombositoz JAMA"},{"key":"10.1016\/j.tracli.2023.08.001_b0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"Philadelphia negative classic myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet","volume":"29","author":"Barbui","year":"2011","journal-title":"JClin Oncol"},{"key":"10.1016\/j.tracli.2023.08.001_b0090","first-page":"296","article-title":"Thrombocypheresis as a preventive measure for complications of asymptomatic cases of idiopathic thrombocythemia","volume":"67","author":"Larison","year":"1978","journal-title":"J Med Assoc Ga"},{"key":"10.1016\/j.tracli.2023.08.001_b0095","first-page":"851","article-title":"Chronic subdural hematoma associated with primary thrombocythemia; Report of a case operated using thrombocythpheresis","volume":"19","author":"Sugawara","year":"1991","journal-title":"There is no Shinkei Geka"},{"key":"10.1016\/j.tracli.2023.08.001_b0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jca.20101","article-title":"Periodic plateletpheresis during pregnancy in a high-risk patient with essential thrombocythemia","volume":"21","author":"Yamaguchi","year":"2006","journal-title":"JClin Apher"},{"key":"10.1016\/j.tracli.2023.08.001_b0105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.transci.2013.08.004","article-title":"Effects of thrombocythpheresis on blood coagulation parameters in healthy donors at the National Blood Centre, Kuala Lumpur","volume":"49","author":"Siti Nadiah","year":"2013","journal-title":"Malaysia Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2023.08.001_b0110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.7754\/Clin.Lab.2013.130807","article-title":"The von Willebrand factor multimer structure is neither acutely nor chronically affected by platelet apheresis","volume":"60","author":"Weiss","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.tracli.2023.08.001_b0115","first-page":"540","article-title":"Improvement of platelet function following plateletpheresis in patients with myeloproliferative diseases","volume":"20","author":"Orlin","year":"1980","journal-title":"Blood Transfusion"},{"key":"10.1016\/j.tracli.2023.08.001_b0120","first-page":"39","article-title":"Morphological features of blood platelets before and after thrombocythapheresis in patients with bronchial asthma","volume":"67","author":"Tatarskii","year":"1995","journal-title":"Ter Arkh"},{"key":"10.1016\/j.tracli.2023.08.001_b0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0955-3886(00)00084-9","article-title":"Single auto-donor thrombocythpheresis increases the plasma level of the endothelial release markers von Willebrand factor and the proinflammatory cytokine tumor necrosis factor-alpha unrelated to fibronectin","volume":"23","author":"Karadogan","year":"2000","journal-title":"Transfus Sci"},{"key":"10.1016\/j.tracli.2023.08.001_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1423-0410.2000.7820101.x","article-title":"Extracorporeal thrombocythpheresis induces the interaction of activated platelets with white blood cells","volume":"78","author":"Gutensohn","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2023.08.001_b0135","first-page":"414","article-title":"Plateletpheresis does not cause prolonged release of platelet-derived growth factor into the donor blood","volume":"45","author":"Zimmermann","year":"2005","journal-title":"Blood Transfusion"},{"key":"10.1016\/j.tracli.2023.08.001_b0140","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/trf.13419","article-title":"Central retinal vein occlusion after plateletpheresis. blood transfusion","volume":"56","author":"Roddy","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.08.001_b0145","first-page":"336","article-title":"Long-term thrombocypheresis in the treatment of primary thrombocytosis blood transfusion","volume":"19","author":"Goldfinger","year":"1979","journal-title":"Transfusion Clinique et Biologique"},{"key":"10.1016\/j.tracli.2023.08.001_b0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1423-0410.1999.7710024.x","article-title":"Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program","volume":"77","author":"Despotis","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2023.08.001_b0155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bjhh.2014.03.008","article-title":"Risk factors associated with the occurrence of adverse events in plateletpheresis donation","volume":"36","author":"Barbosa","year":"2014","journal-title":"Revista Brasileira de FarmacognosiaHematol Hemoter"},{"key":"10.1016\/j.tracli.2023.08.001_b0160","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2023.08.001_b0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2023.08.001_b0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/107602969900500301","article-title":"Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia","volume":"5","author":"Michiels","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.tracli.2023.08.001_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102997","article-title":"Therapeutic leukapheresis and thrombapheresis in medical emergencies","volume":"59","author":"Coffe","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2023.08.001_b0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/1744-9987.12635","article-title":"Therapeutic thrombocytapheresis for symptomatic thrombocytosis in hemato-oncology patients","volume":"22","author":"Prakash","year":"2018","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.tracli.2023.08.001_b0185","first-page":"339","article-title":"Bestimmung der Thrombozytenaggregation aus Spenderblut vor und nach Thrombapherese [Determination of platelet aggregation of donor blood before and after thrombocytapheresis]","volume":"32","author":"Bl\u00e4si","year":"1994","journal-title":"Beitr Infusionsther Transfusionsmed"},{"key":"10.1016\/j.tracli.2023.08.001_b0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0049-3848(02)00274-8","article-title":"Thrombapheresis causes a transient impairment of platelet responsiveness to epinephrine in healthy donors","volume":"107","author":"Choi","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.tracli.2023.08.001_b0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","article-title":"Fibrinogen and fibrin","volume":"70","author":"Weisel","year":"2005","journal-title":"Adv Protein Chem"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782023000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782023000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:40:22Z","timestamp":1761129622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782023000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1246782023000952"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2023.08.001","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of thrombocytapheresis on hemogram and biochemistry parameters in patients with essential thrombocytemia","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2023.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}